share_log

Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights

アナリストの洞察を通じてアニカセラピューティクスを探る

Benzinga ·  05/29 12:00

In the latest quarter, 4 analysts provided ratings for Anika Therapeutics (NASDAQ:ANIK), showcasing a mix of bullish and bearish perspectives.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings02200
Last 30D00100
1M Ago01000
2M Ago00000
3M Ago01100

In the assessment of 12-month price targets, analysts unveil insights for Anika Therapeutics, presenting an average target of $30.0, a high estimate of $37.00, and a low estimate of $22.00. Consistency is reflected as the current average remains at the same level as the previous average price target.

price target chart

Investigating Analyst Ratings: An Elaborate Study

The standing of Anika Therapeutics among financial...

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする